BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25731481)

  • 1. [Treatment strategy for patients with CY1 gastric cancer using subgroup analyses].
    Nagata H; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Sakakura C; Otsuji E
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2235-8. PubMed ID: 25731481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
    Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
    Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.
    Kano K; Aoyama T; Maezawa Y; Nakajima T; Ikeda K; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
    Int J Clin Oncol; 2017 Oct; 22(5):887-896. PubMed ID: 28456896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
    Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
    Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D2-lymphadenectomy improves the survival of patients with peritoneal cytology-positive gastric cancer.
    Inada T; Ogata Y; Kubota T; Ishihara M; Tomikawa M; Ando J; Ozawa I; Hishinuma S; Shimizu H; Kotake K
    Anticancer Res; 2002; 22(1A):291-4. PubMed ID: 12017305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two cases of long-term survival with CY1, stage IV gastric cancer due to surgery and postoperative chemotherapy].
    Tanida T; Aoki T; Igarashi Y; Tsukao Y; Komori T; Matsumoto T; Takachi K; Nishioka K; Uemura Y; Kobayashi K
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2063-5. PubMed ID: 19106524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy with S-1 followed by docetaxel for gastric cancer and CY1P0 peritoneal metastasis after relatively curative surgery.
    Kanazawa Y; Kato S; Fujita I; Onodera H; Uchida E
    J Nippon Med Sch; 2013; 80(5):378-83. PubMed ID: 24189356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is curative gastrectomy justified for gastric cancer with cytology positive as the only stage IV factor?
    Komatsu S; Shioaki Y; Furuke H; Ohta A; Tsuji R; Tanaka S; Kumano T; Imura KI; Shimomura K; Ikeda J; Taniguchi F; Ueshima Y; Lee CJ; Deguchi E; Ikeda E; Otsuji E
    Langenbecks Arch Surg; 2019 Aug; 404(5):599-604. PubMed ID: 31073759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pilot study of neo-adjuvant chemotherapy involving intraperitoneal administration of paclitaxel and oral S-1 for patients with T3 gastric cancer].
    Tamura S; Miki H; Okada K; Yoshimura M; Uji K; Yoshida A; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2024-6. PubMed ID: 19106511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [S-1 monotherapy achieved twenty-month survival for peritoneal lavage cytology-positive gastric cancer patient undergoing noncurative resection].
    Shimoyama S; Kiyokawa T; Nishida M; Seto Y
    Gan To Kagaku Ryoho; 2012 Sep; 39(9):1411-4. PubMed ID: 22996780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
    Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
    Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The future of loco-regional treatment for advanced gastric cancer].
    Nagahama T; Ando M; Ganno H; Ami K; Fukuda A; Maruyama M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2012-4. PubMed ID: 19106507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study).
    Kodera Y; Ito S; Mochizuki Y; Kondo K; Koshikawa K; Suzuki N; Kojima H; Kojima T; Matsui T; Takase T; Tsuboi K; Fujiwara M; Nakao A;
    Eur J Surg Oncol; 2009 Nov; 35(11):1158-63. PubMed ID: 19328643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
    Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
    Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors and usefulness of chemotherapy with S-1 in patients received gastrectomy for stage IV gastric cancer].
    Maehara N; Hidaka H; Nagaike K; Nakashima S; Hotokezaka M; Chijiiwa K
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1111-4. PubMed ID: 19620798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical Impact of adjuvant chemotherapy in patients with T1N2/3 Gastric cancer].
    Tsuchida K; Kunisaki C; Watanabe T; Ono H; Oshima T; Fukushima T; Yoshikawa T; Rino Y; Imada T; Masuda M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2239-41. PubMed ID: 25731482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic strategy for gastric cancer with positive peritoneal lavage cytology without peritoneal dissemination].
    Iwasaki Y; Ohashi M; Iwanaga T; Oohinata R; Yuu K; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
    Gan To Kagaku Ryoho; 2012 Dec; 39(13):2451-4. PubMed ID: 23235163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of neoadjuvant chemotherapy with S-1/CDDP (SP) to the patients with large type 3 and type 4 gastric cancer].
    Katayanagi S; Nomura T; Sumi T; Suda T; Hoshino S; Ito K; Takagi Y; Tsuchida A; Kawachi S; Shimazu M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2214-6. PubMed ID: 24394063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neoadjuvant chemotherapy with combined S-1 plus weekly low-dose cisplatin followed by surgical resection for advanced gastric cancer].
    Isobe T; Hashimoto K; Kizaki J; Miyagi M; Aoyagi K; Koufuji K; Shirouzu K
    Gan To Kagaku Ryoho; 2013 Oct; 40(10):1331-5. PubMed ID: 24105055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis and clinical course of gastric cancer with para-aortic lymph node metastasis after curative D2 gastrectomy and adjuvant chemotherapy with S-1].
    Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A; Rino Y; Masuda M
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2331-3. PubMed ID: 22202372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.